Menu

• Ask a Health Expert about PERNICIOUS ANAEMIA
• Post Your Side Effect related to PERNICIOUS ANAEMIA
• PERNICIOUS ANAEMIA and FDA Warnings
• PERNICIOUS ANAEMIA in Patients Wiki
• Report PERNICIOUS ANAEMIA in Drug Side Effect Survey

PERNICIOUS ANAEMIA side effect

What is PERNICIOUS ANAEMIA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Norvasc Side Effects Report #5674869-7
Physician from JAPAN reported NORVASC problem on Mar 12, 2008. Female patient, 81 years of age, was diagnosed with hypertension and was treated with NORVASC. After drug was administered, patient experienced the following problems/side effects: pernicious anaemia, . NORVASC dosage: DAILY DOSE:5MG-FREQ:DAILY. During the same period patient was treated with TANATRIL. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5333503-6
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Female patient, 32 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: pernicious anaemia, thyroid cancer, . REBIF dosage: unknown. During the same period patient was treated with MINOCYCLINE, TRICOR. Patient recovered.

Rebif Side Effects Report #5337646-2
Physician from UNITED STATES reported REBIF problem on May 15, 2007. Female patient, 32 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: pernicious anaemia, thyroid cancer, . REBIF dosage: unknown. During the same period patient was treated with MINOCYCLINE, TRICOR. Patient recovered.

Metformin Side Effects Report #5626846-X
METFORMIN problem was reported by a Consumer or non-health professional from AUSTRALIA on Jan 31, 2008. Female patient, 60 years of age, was diagnosed with type 2 diabetes mellitus and was treated with METFORMIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, pernicious anaemia, treatment noncompliance, vitamin b12 deficiency, . METFORMIN dosage: 500 MG;TABLET;ORAL;TWICE A DAY. During the same period patient was treated with DIAMICRON, NOVONORM, LEVOTHYROXINE, INDOMETHACIN. Patient recovered.


Diaformin Side Effects Report #5629914-1
Consumer or non-health professional from AUSTRALIA reported DIAFORMIN problem on Jan 31, 2008. Female patient, 60 years of age, was diagnosed with type 2 diabetes mellitus and was treated with DIAFORMIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, pernicious anaemia, . DIAFORMIN dosage: 500 MG;TWICE A DAY;ORAL. During the same period patient was treated with DIAMICRON, NOVONORM, LEVOTHYROXINE, INDOMETHACIN. Patient recovered.

Revlimid Side Effects Report #5766626-8
REVLIMID problem was reported by a Pharmacist from UNITED STATES on May 31, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: multiple myeloma, pernicious anaemia, pneumonia, . REVLIMID dosage: 25 MG, DAILY, ORAL. Patient was hospitalized. Patient recovered.

Byetta Side Effects Report #5648505-X
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Dec 28, 2007. Female patient, 50 years of age, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: fatigue, feeling abnormal, pernicious anaemia, . BYETTA dosage: unknown. During the same period patient was treated with EXENATIDE, AVANDAMET, ATENOLOL, TRIAMTERENE AND HYDROCHLORID. Patient recovered.

Orlistat Side Effects Report #5574486-3
ORLISTAT problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 18, 2007. Female patient, 67 years of age, weighting 216.1 lb, was diagnosed with obesity, hypothyroidism, type 2 diabetes mellitus, gout, hypertension, asthma and was treated with ORLISTAT. After drug was administered, patient experienced the following problems/side effects: dyspnoea, oedema peripheral, pernicious anaemia, rash macular, . ORLISTAT dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, METFORMIN, ALLOPURINOL, FUROSEMIDE, PERINDOPRIL, ATORVASTATIN, SERETIDE, NOVORAPID. Patient was hospitalized. Patient recovered.